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Abstract
Background: The monitoring of intracranial pressure (ICP) has a crucial role in the
surveillance of patients with brain injury. During long-term monitoring of ICP, we
have seen spontaneous shifts in baseline pressure (ICP sensor zero point), which are
of technical and not physiological origin. The aim of the present study was to
explore whether or not baseline pressures of ICP sensors can be affected by
electrostatics discharges (ESD’s), when ESD’s are delivered at clinically relevant
magnitudes.
Methods: We performed bench-testing of a set of commercial ICP sensors. In our
experimental setup, the ICP sensor was placed in a container with 0.9% NaCl
solution. A test person was charged 0.5 - 10 kV, and then delivered ESD’s to the
sensor by touching a metal rod that was located in the container. The continuous
pressure signals were recorded continuously before/after the ESD’s, and the pressure
readings were stored digitally using a computerized system
Results: A total of 57 sensors were tested, including 25 Codman ICP sensors and 32
Raumedic sensors. When charging the test person in the range 0.5-10 kV, typically
ESD’s in the range 0.5 - 5 kV peak pulse were delivered to the ICP sensor. Alterations
in baseline pressure ≥ 2 mmHg was seen in 24 of 25 (96%) Codman sensors and in
17 of 32 (53%) Raumedic sensors. Lasting changes in baseline pressure > 10 mmHg
that in the clinical setting would affect patient management, were seen frequently
for both sensor types. The changes in baseline pressure were either characterized by
sudden shifts or gradual drifts in baseline pressure.
Conclusions: The baseline pressures of commercial solid ICP sensors can be altered
by ESD’s at discharge magnitudes that are clinically relevant. Shifts in baseline
pressure change the ICP levels visualised to the physician on the monitor screen, and
thereby reveal wrong ICP values, which likely represent a severe risk to the patient.
Background
In patients with brain injury due to traumatic brain injury, stroke, or complications to
neurosurgery, the continuous monitoring of intracranial pressure (ICP) is crucial for
surveillance [1-3], even though no randomized trials have confirmed the benefit of ICP
monitoring in patients with brain injury [4].
Modern ICP monitoring was first introduced by Janny in 1950 [5] and Lundberg in
1960 [6]. While ICP initially was mostly measured from fluid-filled catheters in
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reproduction in any medium, provided the original work is properly cited.connection with the ventricular cerebrospinal fluid (CSF), the first ICP micro transdu-
cers were introduced in the 1980’s [7,8]. The ICP micro transducers most commonly
used today include Camino [9] and Codman [10] ICP sensors which were introduced
in the 1980’s, the Spiegelberg ICP sensor [11] introduced in the 1990’s, the Raumedic
ICP sensor introduced in the beginning of 2000 [12], and the Pressio ICP sensor [13]
introduced more recently. There is an extensive literature on the assessment of these
ICP sensors, including bench testing [10,11,13-19] and clinical evaluation [9,12,20-30].
In our hospital, we have particularly addressed the problem of spontaneous shifts in
baseline pressure (zero point) that occur during continuous ICP monitoring. Simulta-
neous monitoring from two ICP sensors placed nearby in the brain demonstrated
spontaneous shifts in baseline pressure, which produced differences in ICP even > 20
mmHg [31]. Since the differences in ICP were accompanied by close to identical ICP
waveforms, the differences in ICP could be explained by shifts in baseline pressure of
technical, not physiological, origin. Similar observations of marked differences in ICP
even > 10-20 mmHg despite identical ICP waveform were done when the ICP sensors
were placed in different intracranial locations [30,32]. Moreover, during long-term ICP
monitoring, sudden shifts in baseline ICP occurred with few hours interval [33]. The
reasons for spontaneous shifts in baseline pressure have not been identified.
The present study was undertaken to explore whether or not commercial ICP sen-
sors are affected by electrostatic discharges (ESD’s). To our knowledge this topic has
previously not been addressed. The issue of electrical safety in hospitals has received
much attention since many years [34-37]. The need for increased awareness of electro-
magnetic interference with medical equipment also was addressed more recently [38].
In the hospital environment, ESD’s can be evoked during patient care such as bedding
of hospital beds [39]. The frequency and severity of ESD’s are affected by numerous
factors such as humidity and temperature, the in-house environment (textiles used in
clothing, antistatic floor and washing).
In this study, we made an experimental set-up to deliver ESD’st oI C Ps e n s o r sa t
magnitudes that are clinically relevant. We tested different types of solid ICP sensors
that have previously been extensively tested and are still widely used, namely the Cod-
man ICP sensor, and the Raumedic NeuroVent and NeuroDur ICP sensors.
Methods
ICP sensors
The following types of commercially available ICP sensors were tested: Codman ICP
MicroSensor (Codman, Johnson & Johnson, Raynham, MA, USA; Figure 1a), Raumedic
NeuroVent P-C (Raumedic AG, Münchberg, GE; Figure 1b), Raumedic NeuroVent P
(Raumedic AG, Münchberg, GE; Figure 1c), and Raumedic NeuroDur sensor (Raume-
dic AG, Münchberg, GE; Figure 1d).
Those ICP sensors that had previously been used in patients were stored in closed
plastic bags at room temperature.
This study did not include research on humans or animals; ethical approval for the
study was not applicable.
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The experimental setup is illustrated in Figure 2. The sensor was placed in a container
filled with 0.9% NaCl solution. Also a metal rod was placed in the container, whereby
a test-person could deliver ESD’s to the sensor. The sensor cable was wrapped around
the container in order to compare with the clinical situation, wherein the cable is
placed on the patient, resulting in increased capacitance. The wrapping procedure was
not done for SensorID’s 1-3. The Codman sensor was connected to a Codman ICP
Express (Codman, Johnson & Johnson, Raynham, MA, USA), which is a pressure trans-
ducer. The Raumedic sensors were connected to a MPR1 Raumedic pressure transdu-
cer (Raumedic AG, Münchberg, GE). The continuous ICP signals from the Codman
ICP express were sampled at 200 Hz using the Sensometrics pressure logger, which is
an analogue to digital converter, and stored on a computer using the Sensometrics
®
software (dPCom A/S, Oslo). The continuous signals provided by the Raumedic MPR-
1 were transferred directly to the computer and stored using Sensometrics
® software.
In order to record the electrostatic levels reached, we used the Stat Arc II model 265
(Monroe Electronics Inc., 100 Housel Ave., Lyndonville, N.Y.).
The testing was done in standardized room temperature of 22-23°C.
Figure 1 The different sensors/sensor transducers applied in this study. In this study we tested the
(a) Codman Microsensor, (b) Raumedic NeuroVent P-C, (c) Raumedic NeuroVent P, and (d) Raumedic
NeuroDur solid sensors.
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After initiating the pressure recording, the test person was charged using a Metriso
5000 insulation tester (Metrawatt GmbH, Germany) and thereafter touching the metal
rod. The test-person was charged in the foll o w i n gs e q u e n c e :0 . 5k V ,1 . 0k V ,2 . 5k V ,
and 5.0 kV. For deliverance of 10 kV, the test person first charged the container to
5kV and then swiftly charged himself to 5 kV opposite polarity before touching the
metal rod. The test-person noted whether or not he detected the current impulse
being delivered.
The testing of a Codman sensor is shown in Additional file 1, and the testing of a
Raumedic sensor is shown in Additional file 2.
Assessment of leakage current
All sensors were tested for leakage current using the Metriso 5000 insulation tester
and a Fluke 87 III True RMS Multimeter (in the voltage range). The procedure of test-
ing for leakage current is shown in Figure 3. All leakage current measurements were
done at 500V unless otherwise stated; resistance was calculated.
Results
ICP sensors
We tested a total of 57 sensors (25 Codman and 32 Raumedic sensors). Six Codman
sensors (SensorID’s 39 and 49-53) and seven Raumedic sensors (SensorID’s 46-48 and
54-57) were new while the other sensors had previously been used in patients. The
proportion of ICP sensors with changes in baseline pressure ≥ 2 mmHg is indicated in
Table 1.
Figure 2 Experimental set-up. The ICP sensor (a) was placed in a container (b) containing 0.9% NaCl
solution. A metal rod (c) was placed in the 0.9% NaCl solution; thereby the test person (d) could deliver
ESD to the sensor (a). The ICP sensor was connected via a cable (e) to the pressure transducer (f), which
was the Codman ICP Express for Codman sensors, and Raumedic MPR-1 for the various Raumedic sensors.
The pressure transducer (f) was further connected with a laptop computer (g) with Sensometrics software
for sampling and storage of the continuous pressure signals. In order to record the ESD delivered to the
sensor, a meter (h) was connected with the container to read the magnitude of ESD.
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though gradual drifts in baseline pressure were seen in two sensors (SensorID’s 7 and
37). The maximum lasting changes in baseline pressure of Codman sensors are shown
in Table 2. Charging the test person to 5 kV caused baseline shift in five sensors (Sen-
sorID’s 37, 38, 40, 41 and 50), with a measured potential change of 2-5 kV in the 0.9%
NaCl solution with the sensor. In the other Codman sensors, changes in baseline pres-
sure occurred when the test person was charged to a 10 kV differential, in which
potential changes to the sensor were comparable to that evoked when charging the
person to 5 kV. For only one sensor (SensorID 38), we managed to deliver a 10 kV
potential change directly to the sensor (taking place after the sensor already had
responded to 5 kV). Figure 4 illustrates shifts in baseline pressure in two sensors, and
Figure 3 Set-up for testing of leakage current. The ICP sensor (a) was placed in a container (b)
containing 0.9% NaCl solution. A metal rod (c) was placed in the 0.9% NaCl solution and connected to
one side of a 500V source (h). All pins of the ICP sensor connector (f) were connected to the Volts input of
the digital multimeter (g) and the multimeter Common input was connected to the other side of the 500V
source. The multimeter’s input impedance of 10 MΩ thus acted as a shunt resistor providing a current
scale of 100pA/mV.
Table 1 ICP sensors tested for altered baseline pressure following ESD
Type of sensor Number Number (%) with change baseline pressure ≥ 2 mmHg
Codman ICP Microsensor 25 24 (96)
Raumedic
NeuroVent P-C 11 11 (100)
NeuroVent P 12 3 (25)
NeuroDur 9 3(33)
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to ESD’s of SensorID 4 is shown in Additional File 3.
The Raumedic sensors responded differently to ESD’s depending on the design of the
sensors. While Raumedic NeuroVent P-C was highly unstable to ESD’s, the Raumedic
NeuroVent P and NeuroDur sensors differed. The maximum lasting changes in base-
line pressure for the individual Raumedic sensors are presented in Table 3.
All the Raumedic NeuroVent P-C sensors responded with gradual drifts in their
baseline pressure; drifts occurred when the test person was charged to 0.5 kV in 3 sen-
sors (SensorID’s 16, 29 and 46), 2.5 kV in 6 sensors (SensorID’s 11-15, and 18), and 5
kV in two sensors (SensorID’s 10 and 57). The gradual drift of NeuroVent P-C in Sen-
sorID 14 is shown in Figure 5a (see also Additional file 4).
The shifts in baseline pressure of NeuroVent P sensors were seen after charging the
test person to 0.5 kV in two (SensorID’s 33 and 47), and to 2.5 kV in another (Sen-
sorID 32). In Figure 5b is illustrated how SensorID 33 gradually changed its baseline
pressure following repetitive ESD’s of 0.5 kV (an animation of the pressure signal is
shown in Additional file 5).
All the three NeuroDur sensors responding to ESD (SensorID’s 23, 25 and 28)
responded when the test person was charged to 0.5 kV, with a corresponding 0.5 kV
potential change in the solution around the sensor. The responses of SensorID’s2 5
and 28 are shown in Figure 6 (see also Additional file 6).
Table 2 Lasting alterations in baseline pressure of Codman sensors following ESD
ICP Sensor Baseline pressure (mmHg)
Codman SensorID Before After Maximum change
1
Microsensor 1 -0.7 -13.3 -12.6
“ 2 0.2 13.4 13.2
“ 3 -1.5 -9.5 -8
“ 4 1.7 -24.4 -26.1
“ 5 -0.02 -1.2 -1.18
“ 6 -0.2 -5 -4.8
“ 7 -0.2 -17.7 -17.5
“ 8 -0.6 8.7 9.3
“ 9 11.5 3.8 -7.7
“ 20 0.5 9.5 9
“ 36 0 4.8 4.8
“ 37 8.8 -5.3 -14.1
“ 38 0 23.2 23.2
“ 39 -0.7 2.8 3.5
“ 40 0.4 40 39.6
“ 41 0 16 16
“ 42 -6.3 -26 -19.7
“ 43 1.8 13.1 11.3
“ 44 -9.3 -0.1 9.2
“ 45 -4.3 0.02 4.32
“ 49 -12.2 -23.1 -10.9
“ 50 -0.1 -15.9 -15.8
“ 51 -15.3 -0.8 14.5
“ 52 4.9 12.5 7.6
“ 53 -0.4 -8.6 -8.2
1Change in baseline pressure ≥ 2 mmHg (absolute value) is highlighted.
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continuous pressure signals retrieved from Codman Microsensor are shown before and after electrostatic
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When the test-person was charged to 0.5 kV, the ESD delivered to the sensor was typi-
cally 0.5 kV pulse peak. Charging to 5 kV provided for a potential change of 2.5 kV on
average (range 2-5 kV). When charging to 10 kV, typically 3.5-4.0 kV change was seen;
in a few occasions we observed even 7 kV change (10 kV on one occasion). While
ESD’s < 3 kV hardly provided any unpleasant sensations, ESD’s of about 5 kV gave
weak unpleasant sensations, while ESD’s ≥ 7 kV provided a sensation which is evident,
though not painful, to the test person.
Table 3 Lasting alterations in baseline pressure of Raumedic sensors following ESD
ICP Sensor Baseline pressure (mmHg)
Raumedic SensorID Before After Maximum change
1
NeuroVent P-C 10 18.4 -9.3 -27.7
“ 11 -0.3 -11.5 -11.2
“ 12 9.5 3.6 -5.9
“ 13 0.6 6.9 6.3
“ 14 -5.4 11.4 16.8
“ 15 -0.7 -14.1 -13.4
“ 16 0 18.3 18.3
“ 18 -1.4 1.1 2.5
“ 29 -5.7 17.3 23
“ 46 -12.1 -0.1 12
“ 57 1.3 -8.3 -9.6
NeuroVent P 17 1.6 0.1 -1.5
“ 30 -0.2 -0.5 -0.3
“ 31 -0.05 -0.9 -0.85
“ 32 -0.3 4.7 5
“ 33 0 9.6 9.6
“ 34 0.2 0.7 0.5
“ 35 0.1 0.5 0.4
“ 47 2.5 -0.1 -2.6
“ 48 0.4 -0.1 -0.5
“ 54 0.6 -0.9 -1.5
“ 55 0.3 0.5 0.2
“ 56 0 -0.1 -0.1
NeuroDur 19 0.1 -0.6 -0.7
“ 21 -0.05 -0.1 -0.05
“ 22 0 0.1 0.1
“ 23 52.4 0.8 -51.6
“ 24 0.8 0.9 0.1
“ 25 0.4 10.7 10.3
“ 26 0.8 0.3 -0.5
“ 27 0.1 0.2 0.1
“ 28 0 39 39
1Change in baseline pressure ≥ 2 mmHg (absolute value) is highlighted.
discharges (ESD’s) for SensorID 4 (a), SensorID 38 (b), and SensorID 7 (c). Note that sudden changes in
baseline pressure occurred for SensorID’s 4 and 38, while SensorID 7 showed gradual drift of baseline
pressure. The baseline pressure level (mmHg) is indicated on the y axis, and the time line on the × axis
levels; the ESD is indicated by an arrow.
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Page 8 of 16Figure 5 Continuous pressure signal from Raumedic sensors before/after electrostatic discharge.
The continuous pressure signals retrieved from Raumedic NeuroVent sensors are shown before and after
electrostatic discharges (ESD’s) for SensorID 14 (NeuroVent P-C; a), and for SensorID 33 (NeuroVent P; b).
The baseline pressure level (mmHg) is indicated on the y axis, and the time line on the × axis levels; the
ESD is indicated by an arrow. Note that gradual drifts in baseline pressure occurred. For SensorID 33,
repeated low ESD’s of 0.5 kV (not being sensed by the test person) causes gradual build-up of baseline
pressures.
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Page 9 of 16Figure 6 Continuous pressure signal from Raumedic sensors before/after electrostatic discharge.
The continuous pressure signals retrieved from Raumedic NeuroDur sensors are shown before and after
electrostatic discharges (ESD’s) of SensorID 28 (a), and for SensorID 25 (b). The baseline pressure level
(mmHg) is indicated on the y axis, and the time line on the × axis levels; the ESD is indicated by an arrow.
Note that gradual drifts in baseline pressure occurred.
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The results of testing leakage current are presented in Table 4. Leakage current was
seen in 1 of the 25 Codman sensors (SensorID 45); this sensor revealed leakage current
of up to100 nA with continuous breakthrough.
The Raumedic sensors differed depending on design. The NeuroVent P-C sensors
showed a marginally higher leakage current. Two of the NeuroVent P sensors respond-
ing to ESD’s (SensorID’s 32 and 33) showed leakage current. The three NeuroDur sen-
sors (SensorID’s 23, 25 and 28) being affected by ESD’s of 0.5 kV, all showed abnormal
current leakage.
Discussion
This study shows that the baseline pressures (zero point) of Codman and Raumedic
ICP sensors can be altered by ESD’s at magnitudes that are clinically relevant. The
observations indicate severe limitations with currently used ICP sensors.
ICP sensors used for clinical monitoring of ICP
The ICP sensors tested in this study are widely used ICP sensors. Both the Codman
[10,14,16,21,22,25,27] and Raumedic [12,19,29,30] sensors have undergone extensive
bench and clinical testing. In general, the assessment of ICP sensors has previously
focused on long-term-drift of the sensors, sensitivity to temperature changes, and
inter-sensor accuracy comparisons [10,11,13-19,22,25].
All the ICP sensors measure pressure relative to atmospheric pressure, which means
that they have to be zeroed before measuring ICP. Hence, their zero point equates the
atmospheric pressure, and the ICP level displayed on the monitor represents the differ-
ence between pressure level within the intracranial compartment and the sensor zero
point. It should be noted that in daily clinical practice, various notations are used to
refer to the zero point, such as set point, reference pressure, or baseline pressure. In
this paper and previous publications [30-33], we have preferred the term baseline pres-
sure, when referring to the zero point of the ICP sensor.
Depending on clinical state, the upper normal threshold of ICP varies between 15
and 25 mmHg [1-4]. Obviously, if the baseline pressure (zero point) spontaneously
shifts > 10-20 mmHg, the ICP presented to the physician becomes wrong. Since the
continuous monitoring of ICP is done for surveillance of patients with brain injury, e.
g. due to traumatic brain injury, stroke complications to brain surgery [1-3], false ICP
values represent a likely hazard to the patient. For example, when ICP increases, efforts
may be done to reduce the ICP; such efforts include medication, artificial ventilation
and surgical procedures.
When the impact of ESD’s on ICP sensors previously has not been considered, the
reason may be that the issues of non-physiological changes in baseline pressure have
not been regarded as a problem in ICP monitoring.
Electrostatic discharges in the hospital environment
There are different ways to test ESD’s; it has also been addressed that there is a need
for more standardized methods [40]. The rational for our experimental setup was to
best possible test ESD’s of clinically relevant magnitudes. Therefore, the ESD’sw e r e
delivered from a test person, and caused pulse peak discharges to the sensor typically
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ICP sensor Test parameters
Type
aSensorID Test Voltage Leakage Current Resistance
Codman Microsensor 1 500 V 70 pA 7 TΩ
Codman Microsensor 2 500 V 80 pA 6 TΩ
Codman Microsensor 3 500 V 130 pA 4 TΩ
Codman Microsensor 4 500 V 60 pA 8 TΩ
Codman Microsensor 5 500 V 60 pA 8 TΩ
Codman Microsensor 6 500 V 100 pA 5 TΩ
Codman Microsensor 7 500 V 60 pA 8 TΩ
Codman Microsensor 8 500 V 90 pA 6 TΩ
Codman Microsensor 9 500 V 50 pA 10 TΩ
Raumedic NeuroVent P-C 10 500 V 150 pA 3 TΩ
Raumedic NeuroVent P-C 11 500 V 140 pA 4 TΩ
Raumedic NeuroVent P-C 12 500 V 110 pA 5 TΩ
Raumedic NeuroVent P-C 13 500 V 270 pA 1.9 TΩ
Raumedic NeuroVent P-C 14 500 V 100 pA 5 TΩ
Raumedic NeuroVent P-C 15 500 V 150 pA 3 TΩ
Raumedic NeuroVent P-C 16 500 V 290 pA 1.7 TΩ
Raumedic NeuroVent P 17 143 V 27.6 μA 5.2 MΩ
Raumedic NeuroVent P-C 18 500 V 300 pA 1.5 TΩ
Raumedic NeuroDur 19 142 V 27.6 μA 5.1 MΩ
Codman Microsensor 20 500 V 50 pA 10 TΩ
Raumedic NeuroDur 21 500 V - 22 Ω
Raumedic NeuroDur 22 142 V 27.6 μA 5.1 MΩ
Raumedic NeuroDur 23 273 V ~16 μA ~17 MΩ
Raumedic NeuroDur 24 142 V 27.6 μA 5.1 MΩ
Raumedic NeuroDur 25 351 V 9.07 μA 38.7 MΩ
Raumedic NeuroDur 26 142 V 27.6 μA 5.1 MΩ
Raumedic NeuroDur 27 142 V 27.6 μA 5.1 MΩ
Raumedic NeuroDur 28 360 V 8 μA4 5 M Ω
Raumedic NeuroVent P-C 29 500 V 130 pA 4 TΩ
Raumedic NeuroVent P 30 142 V 27.6 μA 5.1 MΩ
Raumedic NeuroVent P 31 143 V 27.6 μA 5.2 MΩ
Raumedic NeuroVent P 32 335 V 10.5 μA3 2 M Ω
Raumedic NeuroVent P 33 500 V 200 pA 2.5 TΩ
Raumedic NeuroVent P 34 273 V ~16 μA ~17 MΩ
Raumedic NeuroVent P 35 500 V - 100 Ω
Codman Microsensor 36 500 V 80 pA 6 TΩ
Codman Microsensor 37 500 V 70 pA 7 TΩ
Codman Microsensor 38 500 V 70 pA 7 TΩ
Codman Microsensor 39 500 V 70 pA 7 TΩ
Codman Microsensor 40 500 V 50 pA 10 TΩ
Codman Microsensor 41 500 V 90 pA 6 TΩ
Codman Microsensor 42 500 V 90 pA 6 TΩ
Codman Microsensor 43 500 V 80 pA 6 TΩ
Codman Microsensor 44 500 V 60 pA 8 TΩ
Codman Microsensor 45 500 V 0.5~100 nA ~
Raumedic NeuroVent P-C 46 500 V 210 pA 2.4 TΩ
Raumedic NeuroVent P 47 142 V 27.5 μA 5.2 MΩ
Raumedic NeuroVent P 48 142 V 27.5 μA 5.2 MΩ
Codman Microsensor 49 500 V 100 pA 5 TΩ
Codman Microsensor 50 500 V 210 pA 2.4 TΩ
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below the levels that can be seen clinically [39,41]. ESD’s of magnitudes < 2-3 kV may
not even be appreciated by the personnel taking care of the patients. It was previously
demonstrated that potentials > 30 kV could be induced on the bed framework when
the bedding is pulled from the bed; the degree of charging being dependent on the
material of hospital bedding [39]. In comparison, previous tests in our hospital showed
that ESD’s of 20-40 kV could be seen, depending on the textiles used in clothing (Jen-
sen, Grimnes, unpublished data). Using the test approach described here, we avoided
ESD’s of magnitudes that are not clinically relevant. Only in a few instances, we mana-
ged to deliver 7 kV potential changes to the sensor (10 kV in one sensor that first
responded markedly to 5 kV). Accordingly, the voltages referred to here are quite low.
Different characteristics of Codman and Raumedic ICP sensors
There were some differences between the Codman and Raumedic sensors in their
responses to ESD’s. The Codman sensors consistently responded to electrostatic
changes of 2-3 kV, with sudden shifts in baseline pressure. Gradual drift was only seen
in 2 of 25 Codman sensors (8%). These findings compare with our clinical observations
of spontaneous alterations in baseline ICP despite unchanged ICP waveform. The
observation that baseline pressure was changed maximally > 10 mmHg in 13 of 25
(52%) sensors (and > 20 mmHg in 3 (12%) sensors), indicate that effects of ESD’sa r e
of a magnitude that likely would affect patient management.
The Raumedic sensors responded differently depending on their design. Two types of
responses were seen, namely gradual drifts and sudden shifts in baseline pressure.
W h i l et h eN e u r o V e n tP - Cw a sc o m p l e t e l yu n s t a b l et oE S D ’s, even at levels of 0.5 kV,
the NeuroVent P was less affected. The P-C type incorporates a ceramic coating on
the sensor tip while the P type uses titanium. Also the NeuroDur sensor using tita-
nium was more stable, where the tip seemed connected to the sensor with a 5 MΩ
resistance. Nevertheless, the observation of alterations in baseline pressure > 10 mmHg
in 10 of 32 (31%) Raumedic sensors (> 20 mmHg in 4 of 32 (12.5%) indicate that the
effects of ESD’s would affect patient management also when using these sensors. In a
recent study comparing simultaneous ICP signals from Raumedic NeuroVent and Neu-
roDur sensors, we encountered average differences between sensors during over-night
monitoring > 10 mmHg in 4 of 12 (33%) patients [30].
While leakage current was seen in only one Codman sensor, and no Raumedic Neu-
roVent P-C sensors, current leakage was seen in 2 of 3 Raumedic NeuroVent P sensors
that responded to ESD’s, and in all three Raumedic NeuroDur sensors responding to
ESD’s. The testing of leakage current indicated that in Raumedic titanium sensors
Table 4 Results of testing of current leakage (Continued)
Codman Microsensor 51 500 V 130 pA 4 TΩ
Codman Microsensor 52 500 V 100 pA 5 TΩ
Codman Microsensor 53 500 V 120 pA 4 TΩ
Raumedic NeuroVent P 54 143 V 27.6 μA 5.2 MΩ
Raumedic NeuroVent P 55 143 V 27.6 μA 5.2 MΩ
Raumedic NeuroVent P 56 143 V 27.6 μA 5.2 MΩ
Raumedic NeuroVent P-C 57 500 V 320 pA 1.6 TΩ
SensorID
a: The SensorID’s of new and previously non-used sensors are presented with numbers in bold.
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shell and the connector. Hence, the sensors with resistance different from 5 MΩ
(Table 4) might have a broken protection resistor. We found, however, no evidence of
sensor damage using microscopy, though damage to ICP sensors may happen both
during the implantation and explanation.
Control of risk associated with ESD’s
A major issue with both the Codman and Raumedic ICP sensors is that the health care
personnel get no warning about sudden shifts in baseline pressure (zero point) of ICP
sensors, or even damage to the ICP sensor during/after implantation. Thereby it is
impossible for the physician or nurse to know whether changes in ICP are related to
ESD’s or not. The Codman sensor cannot be re-zeroed because this is done within the
operating room before sensor implantation. The Raumedic sensors, on the other hand,
can be re-zeroed after implantation; however, this procedure is not necessarily done by
the nurse/physician when ICP is changing.
While the present study focused on effects of ESD’s on ICP sensors, the baseline
pressure can also be affected by user-related wrong zeroing or even damage to the sen-
sor during implantation, which may not be recognized. Therefore, it can be questioned
why modern monitoring systems include no warning. Such warning should be incorpo-
rated as part of risk control.
We suggest that a robust way of incorporating risk control is by determining the ICP
from the ICP waveform itself. Thereby quality control is accomplished and the issue of
baseline pressure alterations is eliminated. The first author previously described a proce-
dure for automatic identification of the cardiac-induced waves in the ICP waveform [42].
Using this approach, the ICP parameters such as the mean ICP wave amplitude (MWA),
can be determined from the cardiac induced ICP waves [42]. Since such determination of
single wave pressure parameters is done within the ICP signal itself, the analysis results is
not affected by changes in baseline pressure. The automatic identification of verified car-
diac induced ICP waves also recognizes other ICP sensor-related issues. For example, if an
ICP sensor is placed wrong by mistake, artificial waves and no cardiac induced ICP waves
will be identified, providing feedback to the user that the ICP signal is erroneous.
Conclusions
The baseline pressure (zero point) of the Codman and Raumedic ICP sensors can be
altered by ESD’s at discharge magnitudes that are clinically relevant levels. The shifts
in baseline pressure will directly affect the ICP levels visualised to the health care per-
sonnel. The alterations in baseline pressure can be extensive (> 10-20 mmHg), thereby
revealing wrong ICP values, which subsequently poses a high risk for erroneous
treatment.
Additional material
Additional file 1: The testing of a Codman sensor. The video shows the testing of a Codman sensor. A test
person is being charged, and then touches the metal rod, leading the electrostatic discharge to the container
filled with 0.9% NaCl Ringer solution, wherein the sensor is placed. A schematic illustration is shown in Figure 2.
Additional file 2: The testing of a Raumedic sensor. The video shows the testing of a Raumedic sensor. A test
person is being charged, and then touches the metal rod, leading the electrostatic discharge to the container
filled with 0.9% NaCl Ringer solution, wherein the sensor is placed. A schematic illustration is shown in Figure 2.
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Page 14 of 16Additional file 3: A continuous pressure signal before and after ESD - Codman sensor. The continuous
pressure signal of a Codman sensor (SensorID 4) is shown at a higher velocity (about × 30) than normal. The test
person was charged to 10 kV, which delivered an ESD of 5 kV to the sensor. At the time of the ESD, a sudden
change in baseline pressure occurs. See also Figure 4a.
Additional file 4: A continuous pressure signal before and after ESD - Raumedic NeuroVent P-C sensor.
The continuous pressure signal of a Raumedic P-C sensor (SensorID 14) is shown at a higher velocity (about × 30)
than normal. The test person was charged to 2.5 kV three times, which delivered ESD’s of 1-2.5 kV to the sensor.
At the time of the first ESD, a slight reduction of baseline pressure occurred, while at the second and third ESD’s,
the baseline pressures drifted to higher levels. See also Figure 5a.
Additional file 5: A continuous pressure signal before and after ESD - Raumedic NeuroVent P sensor. The
continuous pressure signal of a Raumedic P sensor (SensorID 33) is shown at a higher velocity (about × 30) than
normal. The test person was repeatedly charged to 0.5 kV, which delivered ESD’s of 0.5 kV to the sensor. At the
time of each ESD, a slight increase of baseline pressure occurred. See also Figure 5b.
Additional file 6: A continuous pressure signal before and after ESD - Raumedic NeuroDur sensor. The
continuous pressure signal of a Raumedic NeuroDur sensor (SensorID 28) is shown at a higher velocity (about ×
30) than normal. The test person was charged to 0.5 kV, which delivered an ESD of 0.5 kV to the sensor. At the
time of ESD, a marked downward drift of baseline pressure occurred. See also Figure 6a.
Abbreviations
ICP: Intracranial pressure; ESD: Electrical discharge; kV: kilo Volt; CSF: cerebrospinal fluid; MWA: mean ICP wave
amplitude; SW: single wave.
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